• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠肿瘤的局部处理

Local management of rectal neoplasia.

作者信息

Touzios John, Ludwig Kirk A

机构信息

Division of General Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

出版信息

Clin Colon Rectal Surg. 2008 Nov;21(4):291-9. doi: 10.1055/s-0028-1089945.

DOI:10.1055/s-0028-1089945
PMID:20011441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2780249/
Abstract

The treatment of rectal neoplasia, whether benign or malignant, challenges the surgeon. The challenge in treating rectal cancer is selecting the proper approach for the appropriate patient. In a small number of rectal cancer patients local excision may be the best approach. In an attempt to achieve two goals-cure of disease with a low rate of local failure and maintenance of function and quality of life-multiple approaches can be utilized. The key to obtaining a good outcome for any one patient is balancing the competing factors that impact on these goals. Any effective treatment aimed at controlling rectal cancer in the pelvis must take into account the disease in the bowel wall itself and the disease, or potential disease, in the mesorectum. The major downside of local excision techniques is the potential of leaving untreated disease in the mesorectum. Local management techniques avoid the potential morbidity, mortality, and functional consequences of a major abdominal radical resection and are thus quite effective in achieving the maintenance of function and quality of life goal. The issue for the transanal techniques is how they fare in achieving the first goal-cure of the cancer while keeping local recurrence rates to an absolute minimum. Without removing both the rectum and the mesorectum there is no completely accurate way to determine whether a rectal cancer has moved outside the bowel wall, so any decision on local management of a rectal neoplasm is a calculated risk. For benign neoplasia, the challenge is removing the lesion without having to resort to a major abdominal procedure.

摘要

直肠肿瘤(无论良性还是恶性)的治疗都给外科医生带来了挑战。治疗直肠癌的挑战在于为合适的患者选择恰当的治疗方法。在少数直肠癌患者中,局部切除可能是最佳方法。为了实现两个目标——以低局部复发率治愈疾病以及维持功能和生活质量,可以采用多种方法。对任何一位患者取得良好治疗效果的关键在于平衡影响这些目标的相互竞争的因素。任何旨在控制盆腔内直肠癌的有效治疗都必须考虑肠壁本身的疾病以及直肠系膜中的疾病或潜在疾病。局部切除技术的主要缺点是可能会遗漏直肠系膜中未治疗的疾病。局部治疗技术避免了大型腹部根治性切除带来的潜在发病率、死亡率和功能后果,因此在实现维持功能和生活质量这一目标方面相当有效。经肛门技术面临的问题是,在将局部复发率降至绝对最低的同时,它们在实现第一个目标(治愈癌症)方面的效果如何。如果不切除直肠和直肠系膜,就没有完全准确的方法来确定直肠癌是否已扩散到肠壁外,所以任何关于直肠肿瘤局部治疗的决定都是一种风险权衡。对于良性肿瘤,挑战在于无需进行大型腹部手术就能切除病变。

相似文献

1
Local management of rectal neoplasia.直肠肿瘤的局部处理
Clin Colon Rectal Surg. 2008 Nov;21(4):291-9. doi: 10.1055/s-0028-1089945.
2
Local excision of rectal cancer.直肠癌局部切除术
World J Surg. 1997 Sep;21(7):706-14. doi: 10.1007/s002689900295.
3
Robotic transanal surgery for local excision of rectal neoplasia, transanal total mesorectal excision, and repair of complex fistulae: clinical experience with the first 18 cases at a single institution.机器人经肛门手术用于直肠肿瘤的局部切除、经肛门全直肠系膜切除及复杂肛瘘修复:单机构首例18例临床经验
Tech Coloproctol. 2015 Jul;19(7):401-10. doi: 10.1007/s10151-015-1283-8. Epub 2015 Feb 24.
4
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
5
Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer.直肠癌经肛门全直肠系膜切除术(TaTME)和腹腔镜全直肠系膜切除术(LapTME)后术后磁共振成像的残留系膜。
Surg Endosc. 2019 Jan;33(1):94-102. doi: 10.1007/s00464-018-6279-9. Epub 2018 Jul 2.
6
Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.新辅助放化疗后残留直肠癌(ypT0-2)经肛门内镜微创手术:另需谨慎。
Dis Colon Rectum. 2013 Jan;56(1):6-13. doi: 10.1097/DCR.0b013e318273f56f.
7
Surgical treatment of adenocarcinoma of the rectum.直肠癌的外科治疗
Ann Surg. 1998 Jun;227(6):800-11. doi: 10.1097/00000658-199806000-00003.
8
Transanal Minimally Invasive Surgery for Local Excision of Benign and Malignant Rectal Neoplasia: Outcomes From 200 Consecutive Cases With Midterm Follow Up.经肛门微创外科手术用于局部切除直肠良恶性肿瘤:200 例连续病例的中期随访结果。
Ann Surg. 2018 May;267(5):910-916. doi: 10.1097/SLA.0000000000002190.
9
Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.经肛门全直肠系膜切除术治疗直肠癌的肿瘤学结果。
Dis Colon Rectum. 2022 Jun 1;65(6):827-836. doi: 10.1097/DCR.0000000000002173. Epub 2022 May 3.
10
The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.经肛门局部切除早期直肠癌对无新辅助放化疗的全直肠系膜切除术的影响:一项系统综述。
Tech Coloproctol. 2021 Sep;25(9):997-1010. doi: 10.1007/s10151-020-02401-8. Epub 2021 Jun 25.

引用本文的文献

1
Endoscopic submucosal dissection versus local excision for early rectal cancer: a systematic review and meta-analysis.内镜黏膜下剥离术与局部切除术治疗早期直肠癌的系统评价和Meta分析
Tech Coloproctol. 2016 Jan;20(1):1-9. doi: 10.1007/s10151-015-1383-5. Epub 2015 Oct 30.
2
Giant rectal villous adenoma: Surgical approach with rectal eversion and perianal coloanal anastomosis.巨大直肠绒毛状腺瘤:采用直肠外翻及肛周结肠肛管吻合术的手术方法
Int J Surg Case Rep. 2014;5(2):97-9. doi: 10.1016/j.ijscr.2013.12.003. Epub 2013 Dec 17.
3
Oncological outcomes of transanal local excision for high risk T(1) rectal cancers.经肛门局部切除术治疗高危 T1 期直肠癌的肿瘤学结局。
World J Gastrointest Oncol. 2012 Apr 15;4(4):84-8. doi: 10.4251/wjgo.v4.i4.84.

本文引用的文献

1
Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database.美国I期直肠癌局部切除率的上升是否合理?:一项来自国家癌症数据库的全国性队列研究。
Ann Surg. 2007 May;245(5):726-33. doi: 10.1097/01.sla.0000252590.95116.4f.
2
Local excision of rectal cancer revisited: ACOSOG protocol Z6041.直肠癌局部切除术再探讨:美国外科医师学会肿瘤学组(ACOSOG)Z6041方案
Ann Surg Oncol. 2007 Feb;14(2):271. doi: 10.1245/s10434-006-9213-7. Epub 2006 Nov 14.
3
The Kraske procedure: a critical analysis of a surgical approach for mid-rectal lesions.克拉斯克手术:对直肠中段病变手术入路的批判性分析。
J Surg Oncol. 2006 Sep 1;94(3):194-202. doi: 10.1002/jso.20591.
4
Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice.经直肠超声检查(TRUS)在普通实践中用于直肠癌治疗前分期的可行性和准确性。
Eur J Surg Oncol. 2006 May;32(4):420-5. doi: 10.1016/j.ejso.2006.01.014. Epub 2006 Mar 6.
5
Transanal endoscopic microsurgical resection of pT1 rectal tumors.经肛门内镜显微手术切除pT1期直肠肿瘤
Dis Colon Rectum. 2006 Feb;49(2):164-8. doi: 10.1007/s10350-005-0269-4.
6
Transanal excision vs. major surgery for T1 rectal cancer.经肛门切除术与T1期直肠癌的大手术对比
Dis Colon Rectum. 2005 Jul;48(7):1380-8. doi: 10.1007/s10350-005-0044-6.
7
Diagnostics of rectal cancer: endorectal ultrasound.直肠癌的诊断:直肠内超声检查。
Recent Results Cancer Res. 2005;165:46-57. doi: 10.1007/3-540-27449-9_7.
8
Surgical salvage of recurrent rectal cancer after transanal excision.经肛门切除术后复发性直肠癌的手术挽救治疗。
Dis Colon Rectum. 2005 Jun;48(6):1169-75. doi: 10.1007/s10350-004-0930-3.
9
Assessment of publication bias in the reporting of EUS performance in staging rectal cancer.
Am J Gastroenterol. 2005 Apr;100(4):808-16. doi: 10.1111/j.1572-0241.2005.41035.x.
10
Recurrence after transanal excision of T1 rectal cancer: should we be concerned?T1期直肠癌经肛门切除术后复发:我们应该担心吗?
Dis Colon Rectum. 2005 Apr;48(4):711-9; discussion 719-21. doi: 10.1007/s10350-004-0666-0.